
Biostatistics for Research That Can Be Published
A clinically relevant question can still fail at peer review if the study design, statistical method, and reported conclusion do not align. Biostatistics is the discipline that creates that alignment. It turns observations from patients, laboratory measurements, surveys, cohorts, and trials into evidence that can be interpreted, challenged, and used responsibly.
For a thesis, specialty dissertation, grant project, or journal manuscript, statistical analysis is not a final technical step performed after data collection. It is part of the research method from the moment the question is defined. This distinction matters because many problems identified by reviewers - inadequate sample size, inappropriate comparisons, missing confounder control, or overstated conclusions - begin long before the analysis file is opened.
What Biostatistics Adds to a Research Study
Biostatistics applies statistical reasoning to biological, medical, and health-related questions. Its purpose is not merely to produce a p-value. A sound analysis estimates the size and direction of an effect, quantifies uncertainty, evaluates whether alternative explanations are plausible, and presents results in a form readers can assess.
Consider a study asking whether a new rehabilitation program improves functional recovery after surgery. The analysis must first clarify what “improves” means. Is the primary outcome a continuous function score, time to return to activity, a binary recovery threshold, or repeated measurements over several visits? Each definition leads to different modeling choices and different assumptions.
This is why the same dataset may support more than one valid analysis, while only one may answer the stated research question well. A simple group comparison may be adequate for a cross-sectional outcome. It may be insufficient when baseline values differ, follow-up observations are correlated, or clinical covariates affect both treatment selection and outcome.
The Biostatistics Decisions That Shape Publication Quality
High-quality research is built through connected methodological decisions. The first is the research question. A question should identify the target population, exposure or intervention, comparator where relevant, outcome, and time frame. Broad questions often produce broad and difficult-to-interpret analyses. Precise questions make variables, eligibility criteria, and statistical models easier to justify.
The second decision is study design. Cross-sectional, case-control, cohort, diagnostic accuracy, randomized trial, and retrospective chart review designs each have different strengths and limitations. A well-executed retrospective study can provide useful evidence, but it cannot automatically establish causality. A randomized design can reduce confounding, but only when allocation, follow-up, adherence, and outcome assessment are handled appropriately.
The third decision is measurement. A variable recorded inconsistently cannot be repaired with an advanced model. Researchers should determine whether outcomes are measured on valid scales, whether exposure definitions are clinically meaningful, and whether the timing of measurement is appropriate. In multi-center or multi-researcher projects, a data dictionary and clear coding plan help prevent avoidable inconsistencies.
Finally, the analysis plan should be specified before examining results whenever possible. Predefining primary and secondary outcomes, planned subgroup analyses, covariates, and missing-data procedures protects the study from selective reporting. It also provides a transparent basis for responding to editorial or reviewer questions.
Choosing the Right Statistical Method
Method selection begins with the outcome, not with software output. Continuous outcomes such as blood pressure, quality-of-life scores, or laboratory values may require t-tests, analysis of variance, linear regression, or mixed-effects models. Binary outcomes such as mortality, treatment response, or presence of disease often call for logistic regression. Time-to-event outcomes require survival analysis methods that account for both event timing and censoring.
The correct method also depends on the structure of the data. Repeated measurements from the same patient are not independent observations. Patients nested within hospitals, students nested within schools, and observations collected across several time points require methods that account for clustering or correlation. Ignoring these features can make confidence intervals appear narrower than they should be.
Adjustment for confounding is another frequent requirement. If age, disease severity, comorbidity burden, or baseline score influences both the exposure and the outcome, an unadjusted comparison may be misleading. Regression modeling, stratification, matching, weighting, or propensity score approaches can help, but their suitability depends on the design and the variables available. No adjustment method can fully correct for major variables that were never measured.
Statistical assumptions deserve the same attention as the final model. Distributional shape, variance patterns, linearity, influential observations, multicollinearity, and model fit should be evaluated rather than assumed. Nonparametric methods, transformations, generalized models, or carefully justified sensitivity analyses may be appropriate when standard assumptions are not met.
Sample Size Is a Scientific Issue, Not a Formality
A sample size calculation should reflect the primary outcome and the smallest effect worth detecting. It should incorporate the selected significance level, desired power, expected variability or event rate, group allocation, and possible loss to follow-up. In diagnostic and prediction studies, sample size considerations may also depend on the number of outcome events and the number of candidate predictors.
An underpowered study can miss a meaningful effect. An excessively large study may detect trivial differences with little clinical relevance. For this reason, reporting effect estimates and confidence intervals alongside p-values is essential. A result can be statistically significant yet clinically unimportant, or statistically nonsignificant while still compatible with a potentially relevant effect because the estimate is imprecise.
From Analysis Output to Defensible Results
Statistical software produces tables. Scientific reporting requires interpretation. Results sections should make it possible for readers to understand who was studied, what was measured, which analyses were planned, and what the estimates mean.
Descriptive tables should summarize the sample without turning every variable into a hypothesis test. Comparative and regression results should identify the effect measure, its confidence interval, and the exact or appropriately reported p-value. For example, an adjusted odds ratio should state the variables included in the model and the outcome category being modeled. A survival analysis should define the event, the start of follow-up, and how censored observations were handled.
Figures can improve clarity when they serve a specific purpose. Kaplan-Meier curves may communicate event-free survival more effectively than a paragraph of percentages. Forest plots can show estimates across subgroups, but subgroup findings need restraint, particularly when they were not prespecified or when sample sizes are small.
The discussion should distinguish association from causation and statistical evidence from clinical interpretation. Limitations should be stated directly. Selection bias, measurement error, residual confounding, missing data, and limited generalizability do not automatically invalidate a study. They do, however, determine how far its conclusions can reasonably extend.
Common Problems That Lead to Revision or Rejection
Many publication-stage statistical problems are preventable. One is testing many outcomes or subgroups without addressing multiplicity or distinguishing exploratory analyses from primary hypotheses. Another is choosing covariates only because they have favorable p-values. Variables should be selected according to clinical knowledge, causal reasoning, and the study objective, not solely automated selection procedures.
A further problem is reporting only significant findings. Null results, missing data patterns, protocol deviations, and sensitivity analyses may materially change interpretation. Transparent reporting is a requirement of scientific ethics, not an obstacle to publication.
Researchers also face a practical trade-off between analytical sophistication and interpretability. A complex model may improve prediction or account for data structure more accurately, but it must be explainable and supported by sufficient data. The best method is not the most complicated one. It is the method that fits the question, design, outcome, and available evidence.
When Expert Biostatistics Support Is Most Valuable
Consultation is most effective before data collection, but it remains useful at every stage. Early support can strengthen protocol development, sample size planning, case report forms, ethics committee materials, and data coding. During analysis, expert review can help identify suitable models, assess assumptions, manage missing data, and produce publication-ready tables and figures.
For graduate theses and indexed journal submissions, the final methodological review is particularly valuable. Editors and reviewers often focus on details that are easy to overlook: consistency between the methods and results sections, correct denominators, appropriate effect measures, transparent exclusions, and conclusions proportionate to the design. Dekartezyen İstatistik supports researchers with discipline-specific analysis and reporting guidance while maintaining scientific ethics and publication standards.
A strong study does not begin with a preferred test or end with a significant p-value. It progresses from a focused question to a defensible design, a transparent analysis, and a conclusion that the data can genuinely support. Treating biostatistics as part of that full research process gives your work a clearer path from data collection to credible publication.




Yorumlar